Revolution Medicines, Inc. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-02-02

Reporting Person: GOLDSMITH MARK A (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-02	Common Stock	M	5000	$1.12	Acquired	5744	Direct
2021-02-02	Common Stock	S	4200	$45.2610	Disposed	1544	Direct
2021-02-02	Common Stock	S	800	$46.2563	Disposed	744	Direct
2020-12-18	Common Stock	G	246604	—	Disposed	247093	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-02	Stock Option (Right to Buy)	$1.12	M	5000	Disposed	2028-04-19	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35953	Indirect
Common Stock	35953	Indirect

Footnotes

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2020.

F3: The transaction was executed in multiple trades in prices ranging from $45.00 to $45.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The transaction was executed in multiple trades in prices ranging from $46.04 to $46.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: On December 2, 2020, Third Rock Ventures GP III, L.P. distributed 27 shares to the Goldsmith Children 2011 Irrevocable Education Trust through an in-kind, pro rata distribution without value. This distribution was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9.

F6: Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.

F7: Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.

F8: This transaction involved a gift of securities by the Reporting Person.

F9: On December 2, 2020, Third Rock Ventures GP III, L.P. distributed 245 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust through an in-kind, pro rata distribution without value. This distribution was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9.

F10: Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

F11: This option is early exercisable. One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from March 29, 2018 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.